Trademark Snap Shot Amendment & Mail Processing Stylesheet (Table presents the data on Amendment & Mail Processing Complete) |
|||
OVERVIEW |
|||
SERIAL NUMBER | 86705455 | FILING DATE | 07/27/2015 |
REG NUMBER | 0000000 | REG DATE | N/A |
REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
INTL REG # | N/A | INTL REG DATE | N/A |
TM ATTORNEY | ZASKODA, ERIN RENE |
L.O. ASSIGNED | 103 |
PUB INFORMATION |
|||
RUN DATE | 10/21/2016 | ||
PUB DATE | N/A | ||
STATUS | 661-RESPONSE AFTER NON-FINAL-ACTION-ENTERED | ||
STATUS DATE | 10/20/2016 | ||
LITERAL MARK ELEMENT | LIVING DRUGS IN A BAG | ||
DATE ABANDONED | N/A | DATE CANCELLED | N/A |
SECTION 2F | NO | SECTION 2F IN PART | NO |
SECTION 8 | NO | SECTION 8 IN PART | NO |
SECTION 15 | NO | REPUB 12C | N/A |
RENEWAL FILED | NO | RENEWAL DATE | N/A |
DATE AMEND REG | N/A |
FILING BASIS |
|||||
FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
44D | NO | 44D | NO | 44D | NO |
44E | NO | 44E | NO | 44E | NO |
66A | NO | 66A | NO | ||
NO BASIS | NO | NO BASIS | NO |
MARK DATA |
|
STANDARD CHARACTER MARK | YES |
LITERAL MARK ELEMENT | LIVING DRUGS IN A BAG |
MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
PARTY TYPE | 10-ORIGINAL APPLICANT |
NAME | NantKwest, Inc. |
ADDRESS | 2533 South Coast Highway 101 The Plastino Building, Suite 210 Cardiff-by-the Sea, CA 920072133 |
ENTITY | 03-CORPORATION |
CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
INTERNATIONAL CLASS | 001 |
DESCRIPTION TEXT | Cells for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; cell-derived preparations, namely, natural killer cell-derived preparations, for scientific, laboratory, medical, clinical, therapeutic, and diagnostic research; kits comprised of cells, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, and therapeutic research purposes |
INTERNATIONAL CLASS | 005 |
DESCRIPTION TEXT | Cells for clinical, medical, and therapeutic purposes; cell-derived preparations, namely, natural killer cell-derived preparations, for clinical, medical, and therapeutic purposes; therapeutic products derived from cells, namely, natural killer cells, for clinical, medical, and therapeutic purposes; therapeutic products derived from cell-derived preparations, namely, natural killer cell-derived preparations, for clinical, medical, and therapeutic purposes; kits comprised of cells, reagents and related instructions, for clinical, medicinal, and therapeutic purposes; kits comprised of cell-derived preparations, namely, natural killer cell-derived preparations, reagents and related instructions, for clinical, medicinal, and therapeutic purposes |
INTERNATIONAL CLASS | 042 |
DESCRIPTION TEXT | Research in the field of cancer; product development in the fields of science, medicine, pharmaceuticals, therapeutics and research related thereto |
GOODS AND SERVICES CLASSIFICATION |
|||||||
INTERNATIONAL CLASS | 001 | FIRST USE DATE | 01/00/2016 | FIRST USE IN COMMERCE DATE | 01/00/2016 | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 005 | FIRST USE DATE | 01/00/2016 | FIRST USE IN COMMERCE DATE | 01/00/2016 | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 042 | FIRST USE DATE | 01/00/2016 | FIRST USE IN COMMERCE DATE | 01/00/2016 | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
CHANGE IN REGISTRATION | NO |
PROSECUTION HISTORY |
||||
DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
10/20/2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 020 |
10/20/2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 019 |
10/14/2016 | ALIE | A | ASSIGNED TO LIE | 018 |
10/05/2016 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 017 |
09/09/2016 | DOCK | D | ASSIGNED TO EXAMINER | 016 |
06/02/2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 015 |
06/02/2016 | GNRT | O | NON-FINAL ACTION E-MAILED | 014 |
06/02/2016 | CNRT | R | NON-FINAL ACTION WRITTEN | 013 |
05/13/2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 012 |
05/12/2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 011 |
05/12/2016 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 010 |
05/13/2016 | AUPC | I | AMENDMENT TO USE PROCESSING COMPLETE | 009 |
05/13/2016 | IUAF | S | USE AMENDMENT FILED | 008 |
05/12/2016 | EAAU | I | TEAS AMENDMENT OF USE RECEIVED | 007 |
11/12/2015 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 006 |
11/12/2015 | GNRT | F | NON-FINAL ACTION E-MAILED | 005 |
11/12/2015 | CNRT | R | NON-FINAL ACTION WRITTEN | 004 |
11/05/2015 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
07/31/2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
07/31/2015 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
ATTORNEY | Alicia M. Passerin |
CORRESPONDENCE ADDRESS | ALICIA M. PASSERIN Pietragallo Gordon Alfano Bosick & Raspa 1 Oxford Ctr Pittsburgh, PA 15219-1400 |
DOMESTIC REPRESENTATIVE | NONE |